
Fluidigm Corporation FLDM
Fluidigm Corporation EV - Enterprise Value | FLDM
Annual EV - Enterprise Value Fluidigm Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 6.64 M | -1.37 M | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.64 M | -1.37 M | 2.64 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Myriad Genetics
MYGN
|
598 M | $ 5.47 | -1.26 % | $ 507 M | ||
|
Precipio
PRPO
|
42.5 M | $ 17.46 | -5.6 % | $ 28 M | ||
|
ENDRA Life Sciences
NDRA
|
7.31 M | $ 3.58 | -3.38 % | $ 4.74 M | ||
|
QIAGEN N.V.
QGEN
|
-839 M | $ 49.28 | -0.72 % | $ 10.7 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 14.8 | -1.95 % | $ 1.9 B | ||
|
OPKO Health
OPK
|
1.34 B | $ 1.58 | -2.17 % | $ 1.19 B | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.64 | -7.1 % | $ 492 M | ||
|
Neogen Corporation
NEOG
|
3.58 B | $ 10.45 | -3.73 % | $ 2.27 B | ||
|
Personalis
PSNL
|
380 M | $ 14.29 | -2.96 % | $ 1.28 B | ||
|
Quidel Corporation
QDEL
|
460 M | $ 8.31 | -6.84 % | $ 350 M | ||
|
Centogene N.V.
CNTG
|
-8.4 M | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
21.6 B | $ 438.11 | -4.11 % | $ 26.1 B | ||
|
Neuronetics
STIM
|
168 M | $ 1.24 | -4.44 % | $ 81.8 M | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 6.24 | 13.76 % | $ 2.24 B | ||
|
Exagen
XGN
|
78.4 M | $ 3.59 | -5.53 % | $ 77.4 M | ||
|
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
654 M | - | 0.12 % | $ 80.1 M | ||
|
VolitionRx Limited
VNRX
|
66.5 M | $ 0.16 | -1.97 % | $ 20.1 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
432 M | $ 25.18 | 0.76 % | $ 564 M | ||
|
Twist Bioscience Corporation
TWST
|
6.27 B | $ 103.2 | -7.54 % | $ 6.46 B | ||
|
Organovo Holdings
ONVO
|
3.46 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
5.67 M | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Renalytix AI plc
RNLX
|
33.9 M | - | 5.66 % | $ 22.7 M | ||
|
Meridian Bioscience
VIVO
|
1.3 B | - | - | $ 1.49 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | ||
|
T2 Biosystems
TTOO
|
54.9 M | - | -39.35 % | $ 313 K | ||
|
Syneos Health
SYNH
|
4.59 B | - | - | $ 4.46 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Quotient Limited
QTNT
|
273 M | - | -11.32 % | $ 1.1 M | ||
|
Brainsway Ltd.
BWAY
|
231 M | $ 8.53 | -2.29 % | $ 290 M | ||
|
Burning Rock Biotech Limited
BNR
|
-193 M | $ 13.46 | 1.05 % | $ 142 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 609.81 | -3.81 % | $ 17.6 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
578 M | - | - | $ 608 M | ||
|
RadNet
RDNT
|
7.26 B | $ 69.77 | 0.37 % | $ 5.25 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
1.77 M | - | -1.84 % | $ 15.3 M | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
184 M | $ 7.55 | -9.1 % | $ 57 M |